Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision tag was updated from v3.6.4 to v3.6.5, indicating a new page build. No study content or data were changed.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page no longer displays the primary disease label 'Multiple myeloma'. It also removes the 'related topics' header and the 'MedlinePlus Genetics' resource link, reducing context and navigational options for readers.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a minor deployment update to the page template/renderer. There is no indication of changes to the study data or visible content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now lists 'Multiple myeloma' and a related topics section including MedlinePlus Genetics, and the site's revision tag is updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.6.2 was added. The page's related topics section was pruned to remove 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.0', leaving the update focused on versioning rather than study content.SummaryDifference0.2%

- Check67 days agoChange DetectedAdded navigation and help sections such as 'Last verified', 'Last known status was', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus related topic links (Intervention/Treatment, Multiple myeloma, MedlinePlus Genetics) and updated the revision tag to v3.6.0. Removed older labels including 'Verified', 'Last known status was:', 'Intervention / Treatment', and 'Revision: v3.5.5'.SummaryDifference2%

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.